Delivery Order SPE2DR25D3301-SPE2DR26F28EF
Award Date 5/6/26
Potential Completion Date 5/7/26
Potential Value $7.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $3,327.57 delivery order to Amerisourcebergen Drug Corp on May 2, 2026, for VIVITROL 380 MG vial-diluents, with ultimate completion on May 4, 2026. Place of performance is Conshohocken, PA. The order is a firm fixed-price award with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December...
- The Defense Logistics Agency issued a $1,109.19 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for Vivitrol 380 mg vial-diluents, with ultimate completion on April 28, 2026. Place of performance is Conshohocken, PA. The order was issued on a firm fixed-price basis with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier operating as a subsidiary of Cencora, Inc., and holds a single-award indefinite delivery contract (SPE2DX) with the...
- The Defense Logistics Agency issued a $13,964.22 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for VIVITROL 380 mg vial-diluents with an ultimate completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to Defense and...
- The Defense Logistics Agency issued a $11,553.62 delivery order to Amerisourcebergen Drug Corp on May 4, 2026, for Vivitrol 380 mg vial-diluents with an ultimate completion date of May 5, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to federal healthcare...
- The Defense Logistics Agency issued a $5,545.95 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for VIVITROL 380 mg vials with diluents. Place of performance is Conshohocken, PA; ultimate completion date is April 30, 2026. The order is firm fixed-price with no set-aside. Amerisourcebergen is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Department of Defense and federal healthcare systems. The company holds a single-award indefinite...
- The Defense Logistics Agency issued a $20,685.38 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for Vivitrol 380 mg vial and diluents, with ultimate completion on April 28, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing on full-and-open competitive awards. The company holds a single-award indefinite delivery...
- The Defense Logistics Agency issued a $3,732.58 delivery order to Amerisourcebergen Drug Corp on April 24, 2026, for Vivitrol 380 mg vial-diluents, with ultimate completion on April 27, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen operates as a pharmaceutical distributor and medical supplier delivering brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to Defense and federal healthcare...
- The Defense Logistics Agency issued a $7,971.54 delivery order to Amerisourcebergen Drug Corp on April 21, 2026, for Vivitrol 380 mg vials and diluents, with an ultimate completion date of April 22, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed-price under a full-and-open competitive award with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying brand-name and generic medications, specialty...
- The Defense Logistics Agency issued a $4,436.76 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for VIVITROL 380 mg vials with diluents. The order is firm fixed-price with an ultimate completion date of April 23, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Defense Logistics Agency under standing indefinite delivery...
- The Defense Logistics Agency issued a $2,218.38 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for VIVITROL 380 MG vials and diluents, with completion by April 28, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen operates as a pharmaceutical distributor and medical supplier serving Defense Health Agency and military medical facilities globally under the DLA Troop Support Medical indefinite delivery contract...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F28EFDelivery Order
The Defense Logistics Agency issued a $7,332.18 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for VIVITROL 380 MG vial and diluents, with ultimate completion by May 7, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor and medical supplier to federal healthcare systems. The company holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Generated 8/4/26, 11:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 5/5/26 |